The role of nasal immunoglobulins in the recovery of olfactory function in COVID-19 patients.

Luigi Angelo Vaira, Jerome R Lechien, Giovanni Salzano, Fabio Maglitto, Sven Saussez, Giacomo De Riu

Open access · greenAbstract readLetterComment

In one paragraph

Article in American journal of otolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

1.0field-weighted citation impact, top 30% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

Post-Viral Olfactory Loss: What We Learned from the SARS-CoV-2 Pandemic.Life (Basel, Switzerland) · 2022
Article
The Effects of Persistent Olfactory and Gustatory Dysfunctions on Quality of Life in Long-COVID-19 Patients.Life (Basel, Switzerland) · 2022
Article

4 · The record

Corrections and comments

Comment on
Clinical, virological and immunological evolution of the olfactory and gustatory dysfunction in COVID-19.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

Luigi Angelo VairaMaxillofacial Surgery Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Italy; Biomedical Science Department, PhD School of Biomedical Science, University of Sassari, Sassari, Italy. Electronic address: lavaira@uniss.it.

Jerome R LechienDepartment of Otolaryngoly-Head Neck Surgery, Foch Hospital, Paris Saclay University, Paris, France; Department of Human and Experimental Oncology, Faculty of Medicine UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.

Giovanni SalzanoMaxillofacial Surgery Operative Unit, University Hospital of Naples "Federico II", Naples, Italy.

Fabio MaglittoMaxillofacial Surgery Operative Unit, University Hospital of Naples "Federico II", Naples, Italy.

Sven SaussezDepartment of Human and Experimental Oncology, Faculty of Medicine UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.

Giacomo De RiuMaxillofacial Surgery Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Italy; Biomedical Science Department, PhD School of Biomedical Science, University of Sassari, Sassari, Italy.

University of Mons · BEUniversity of Sassari · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Olfaction DisordersAnosmiaHumansImmunoglobulinsSARS-CoV-2SmellImmunoglobulinsAnosmiaCoronavirusCorticosteroidsCovid-19SARS-CoV-2Smell disordersTherapy

Identifiers

PMID34895763

DOI10.1016/j.amjoto.2021.103301

PMCPMC8638244

OpenAlexW4200569343

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.